Clinical Trial Update: Long-term Efficacy and Safety Study With Oralgen Grass Pollen [Phase 2, Phase 3]

View source ↗

Summary

The document announces the completion of a long-term efficacy and safety study (Phase 2/Phase 3) evaluating Oralgen Grass Pollen for allergic rhinoconjunctiviti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis

Drugs mentioned

• Oralgen Grass Pollen

Snippet

Sponsor: Artu Biologicals | Conditions: Allergic Rhinoconjunctivitis | Phase 2, Phase 3 | Status: COMPLETED